Pharma Focus Asia

Pharma Focus Asia Pharma Focus Asia - Magazine for Pharma Industry Leaders
https://www.linkedin.com/company/pharmafocusasia/ Ltd.. Pharma Focus Asia offers . . .

Pharma Focus Asia is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the worldโ€™s leading pharmaceutical companies. Pharma Focus Asia covers important issues and trends shaping the future of the pharma industry across Asia and rest of the world. Dedicated, reliable and accurate coverage of the industryโ€™s progress and
Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:

Strategy
Research and Development
Manufacturing
Clinical Trials
Information Technology


The one-stop pharma destination www.pharmafocusasia.com features complete content from the Pharma Focus Asia magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership

The magazineโ€™s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on Asia, Pharma Focus Asia reaches out to the key industry leaders across Asia, Europe and the Americas.

Biomanufacturing is rapidly evolving to meet global demand for faster, more flexible, and cost-effective biologics produ...
30/01/2026

Biomanufacturing is rapidly evolving to meet global demand for faster, more flexible, and cost-effective biologics production.

With connected systems, real-time data, and automated operations, the biopharma facility of the future is becoming a reality.

Digital bioprocessing platforms are helping manufacturers improve productivity, ensure quality, and build resilient, on-demand supply chainsโ€”while meeting increasingly complex regulatory expectations.

๐Ÿ‘‰ ๐’๐ž๐ž ๐ก๐จ๐ฐ ๐๐ข๐ ๐ข๐ญ๐š๐ฅ ๐ญ๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐ข๐ฌ ๐ฌ๐ก๐š๐ฉ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐›๐ข๐จ๐ฉ๐ก๐š๐ซ๐ฆ๐š ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐ :
https://www.pharmafocusasia.com/articles/envisioning-the-biomanufacturing-facility-of-the-future

Convex dose dependence in gene expression isnโ€™t always what it seems.New analytical studies show that non-monotonic (con...
29/01/2026

Convex dose dependence in gene expression isnโ€™t always what it seems.

New analytical studies show that non-monotonic (convex) dose-response patterns can occur with both single and multiple drug treatments, challenging long-held assumptions about drug interaction effects.

With high-throughput sequencing now measuring tens of thousands of genes simultaneously, selecting truly drug-responsive targets requires advanced data-driven evaluation methodsโ€”not just traditional dose-response logic.

๐Ÿ‘‰ ๐†๐ž๐ญ ๐๐ž๐ž๐ฉ๐ž๐ซ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐๐จ๐ฌ๐ž ๐๐ž๐ฉ๐ž๐ง๐๐ž๐ง๐œ๐ž ๐š๐ง๐ ๐ฌ๐ฆ๐š๐ซ๐ญ๐ž๐ซ ๐๐ซ๐ฎ๐  ๐ž๐ฏ๐š๐ฅ๐ฎ๐š๐ญ๐ข๐จ๐ง:
https://www.pharmafocusasia.com/articles/is-convex-dose-dependence-a-side-effect-that-multiple-drug-treatment-causes

3D printing combined with nanotechnology is changing the ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ. From nano-dosage forms and diagnosti...
28/01/2026

3D printing combined with nanotechnology is changing the ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ. From nano-dosage forms and diagnostic sensors to tissue engineering and bone regeneration, this technology is enabling smarter, faster, and more patient-centric healthcare solutions.

With real-world applications already approved by regulatorsโ€”and more innovations in the pipelineโ€”the pharma industry must stay informed about both ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐ฉ๐จ๐ญ๐ž๐ง๐ญ๐ข๐š๐ฅ ๐š๐ง๐ ๐ซ๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ซ๐ž๐š๐๐ข๐ง๐ž๐ฌ๐ฌ.

๐Ÿ‘‰ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž to read the complete article and stay updated on next-generation pharma technologies.
https://www.pharmafocusasia.com/articles/3d-printing-revolutionising-nanotechnology

๐‚๐š๐ง๐œ๐ž๐ซ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ has transformed outcomesโ€”but immune suppression in the tumor microenvironment remains a major barri...
27/01/2026

๐‚๐š๐ง๐œ๐ž๐ซ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ has transformed outcomesโ€”but immune suppression in the tumor microenvironment remains a major barrier.

In this in-depth feature, ๐Œ๐š๐๐ฌ ๐‡๐š๐ฅ๐ ๐€๐ง๐๐ž๐ซ๐ฌ๐ž๐ง, ๐ƒ๐Œ๐’๐œ, ๐ƒ๐’๐œ๐“๐ž๐œ๐ก, ๐๐ก๐ƒ, Director and Professor at the National Center for Cancer Immune Therapy, Copenhagen University Hospital Herlev, explains how immune modulatory vaccines (IMVs) work as next-generation combination agents. By targeting immunosuppressive cells rather than single molecules, IMVs can enhance checkpoint inhibitors, cancer vaccines, cellular therapies, and even chemo-radiotherapy.

This emerging modality also shows promise beyond oncology, including ๐œ๐ก๐ซ๐จ๐ง๐ข๐œ ๐ฏ๐ข๐ซ๐š๐ฅ ๐ข๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ ๐Ÿ๐ข๐›๐ซ๐จ๐ฌ๐ข๐ฌโ€”opening new avenues for pharma R&D and lifecycle strategies.

๐Ÿ‘‰ ๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐š๐ง๐ ๐ฌ๐ž๐ž ๐ก๐จ๐ฐ ๐ˆ๐Œ๐•๐ฌ ๐œ๐š๐ง ๐ซ๐ž๐ฌ๐ก๐š๐ฉ๐ž ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ ๐œ๐จ๐ฆ๐›๐ข๐ง๐š๐ญ๐ข๐จ๐ง๐ฌ:
https://www.pharmafocusasia.com/articles/redefining-therapeutics

The pharma world moves fastโ€”and staying informed makes all the difference.The ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐„๐ฆ๐š๐ข๐ฅ ๐๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ deliver...
23/01/2026

The pharma world moves fastโ€”and staying informed makes all the difference.

The ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐„๐ฆ๐š๐ข๐ฅ ๐๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ delivers trusted updates from across the industry, including expert articles, interviews, news, technology trends, research insights, events, podcasts, and our latest magazineโ€”all in one place.

Join a growing community of pharma professionals who rely on timely, relevant, and actionable information.
https://industry.pharmafocusasia.com/e-newsletters/1769083479-Jan-2026.html

๐Ÿ‘‰ ๐’๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐›๐ž ๐ญ๐จ๐๐š๐ฒ ๐š๐ง๐ ๐ฌ๐ก๐š๐ซ๐ž ๐ข๐ญ ๐ฐ๐ข๐ญ๐ก ๐ฒ๐จ๐ฎ๐ซ ๐œ๐จ๐ง๐ง๐ž๐œ๐ญ๐ข๐จ๐ง๐ฌ:
https://www.pharmafocusasia.com/subscribe

Medicine heals peopleโ€”but what about the planet? ๐ŸŒฑThe ๐†๐ซ๐ž๐ž๐ง ๐‘๐ž๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐ข๐ง ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž highlights a powerful shift in pharma...
23/01/2026

Medicine heals peopleโ€”but what about the planet? ๐ŸŒฑ

The ๐†๐ซ๐ž๐ž๐ง ๐‘๐ž๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐ข๐ง ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž highlights a powerful shift in pharmaceutical science: creating medicines that are not only effective for patients but also safe for the environment. From reducing toxic solvents to adopting plant-based synthesis and biodegradable drug delivery systems, this article outlines how sustainability can reshape healthcare for future generations.

โœ๏ธ Written by: Aishwarya Jain
Department of Pharmaceutics, Shri Vile Parle Kelavani Mandal's College of Pharmacy

This is a must-read for pharma professionals committed to responsible innovation and long-term global health.

๐Ÿ‘‰ ๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐š๐ง๐ ๐ฌ๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ ๐ฉ๐ฅ๐š๐ง๐ž๐ญ-๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐ž ๐ก๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž: https://www.pharmafocusasia.com/articles/the-green-revolution-in-medicine

Healthcare evidence is changingโ€”and patient voice is no longer optional.In a compelling interview, ๐ƒ๐ข๐ฆ๐ฉ๐ฅ๐ž ๐ƒ๐š๐ง๐ , ๐‚๐จ-๐…๐จ๐ฎ๐ง๐...
22/01/2026

Healthcare evidence is changingโ€”and patient voice is no longer optional.

In a compelling interview, ๐ƒ๐ข๐ฆ๐ฉ๐ฅ๐ž ๐ƒ๐š๐ง๐ , ๐‚๐จ-๐…๐จ๐ฎ๐ง๐๐ž๐ซ & ๐ƒ๐ข๐ซ๐ž๐œ๐ญ๐จ๐ซ ๐š๐ญ ๐Œ๐š๐ซ๐ค๐ฌ๐Œ๐š๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž, explains how HEOR is moving beyond listening to patients toward leading evidence strategies built around real-world experience.

The discussion covers patient-generated data, AI-driven insights, regulatory expectations, and how meaningful patient-centred evidence can influence outcomes, access, and sustainability across healthcare systems.

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐ข๐ง๐ญ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐š๐ง๐ ๐ฌ๐ญ๐š๐ฒ ๐š๐ก๐ž๐š๐ ๐ข๐ง ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ-๐Ÿ๐จ๐œ๐ฎ๐ฌ๐ž๐ ๐‡๐„๐Ž๐‘:
https://www.pharmafocusasia.com/interviews/from-listening-to-leading-reimagining-heor-through

Automation and digitalization are redefining industrial microbiology in pharma manufacturing. With rising regulatory scr...
21/01/2026

Automation and digitalization are redefining industrial microbiology in pharma manufacturing. With rising regulatory scrutiny and faster drug development timelines, traditional QC methods are struggling to keep pace.

Digital microbiology workflows help reduce human error, improve traceability, ensure data integrity, and accelerate product releaseโ€”while supporting sustainability through paperless labs. From robotic sample handling to real-time process monitoring, the lab of the future is already taking shape.

The result? Better quality, faster decisions, and stronger confidence in every batch.

๐Ÿ‘‰ ๐’๐ž๐ž ๐ก๐จ๐ฐ ๐ฉ๐ก๐š๐ซ๐ฆ๐š ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐š๐ซ๐ž ๐š๐๐ฏ๐š๐ง๐œ๐ข๐ง๐  ๐ฆ๐ข๐œ๐ซ๐จ๐›๐ข๐จ๐ฅ๐จ๐ ๐ฒ ๐ฐ๐ข๐ญ๐ก ๐š๐ฎ๐ญ๐จ๐ฆ๐š๐ญ๐ข๐จ๐ง:
https://www.pharmafocusasia.com/articles/advancing-automation-and-digitalization-in-the-industrial-microbiology-workflow

๐€๐ ๐ž-๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐Œ๐š๐œ๐ฎ๐ฅ๐š๐ซ ๐ƒ๐ž๐ ๐ž๐ง๐ž๐ซ๐š๐ญ๐ข๐จ๐ง remains a leading cause of irreversible vision loss, yet traditional therapies face lim...
20/01/2026

๐€๐ ๐ž-๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐Œ๐š๐œ๐ฎ๐ฅ๐š๐ซ ๐ƒ๐ž๐ ๐ž๐ง๐ž๐ซ๐š๐ญ๐ข๐จ๐ง remains a leading cause of irreversible vision loss, yet traditional therapies face limitations due to ocular barriers and frequent invasive injections. Nanotechnology-based drug delivery systems are changing this narrative by enabling targeted, sustained, and safer delivery of anti-VEGF therapies directly to retinal tissues.

From polymer and lipid nanoparticles to advanced nanodiagnostics, these innovations are improving treatment outcomes while enhancing patient comfort and compliance. As research accelerates, nanomedicine is set to play a pivotal role in the future of retinal disease management.

๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐ซ๐ž๐š๐ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ ๐จ๐ง ๐ง๐š๐ง๐จ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซ ๐€๐Œ๐ƒ: https://www.pharmafocusasia.com/articles/nanotechnology-strategies-for-age-related-macular-degeneration

Behind every successful pharma partnership is patience, empathy, and genuine understanding.In a compelling interview, ๐๐ซ...
09/01/2026

Behind every successful pharma partnership is patience, empathy, and genuine understanding.

In a compelling interview, ๐๐ซ๐š๐ ๐š๐ญ๐ก๐ข ๐˜๐š๐๐ก๐š๐ญ๐ข, ๐‚๐ฅ๐ข๐ž๐ง๐ญ ๐‘๐ž๐ฅ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐Ž๐Ÿ๐Ÿ๐ข๐œ๐ž๐ซ ๐š๐ญ ๐๐จ๐ณ๐ž๐’๐œ๐š๐Ÿ ๐ˆ๐ง๐œ., explains why strong scientific collaborations are built on trustโ€”not transactions.

From navigating long sales cycles to listening beyond whatโ€™s spoken, this piece sheds light on the human side of pharma business development.

๐Ÿ‘‰ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐ซ๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐ข๐ง๐ญ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ ๐š๐ง๐ ๐ ๐š๐ข๐ง ๐ซ๐ž๐š๐ฅ-๐ฐ๐จ๐ซ๐ฅ๐ ๐๐ƒ ๐ฉ๐ž๐ซ๐ฌ๐ฉ๐ž๐œ๐ญ๐ข๐ฏ๐ž๐ฌ:
https://www.pharmafocusasia.com/interviews/the-human-side-of-pharma-bd

๐€๐๐€๐‚ ๐ข๐ฌ ๐ซ๐ž๐ฌ๐ก๐š๐ฉ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐ญ๐ซ๐ข๐š๐ฅ๐ฌโ€”and supply-chain strategy is at the center of it.In Pharma Focus Asiaโ€”Is...
08/01/2026

๐€๐๐€๐‚ ๐ข๐ฌ ๐ซ๐ž๐ฌ๐ก๐š๐ฉ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐ญ๐ซ๐ข๐š๐ฅ๐ฌโ€”and supply-chain strategy is at the center of it.

In Pharma Focus Asiaโ€”Issue 61, Kevin Cheong, Director of Clinical Operations, APAC at Almac Clinical Services, discusses how Almac is driving innovation through advanced cold-chain management, digital supply visibility, and sustainable clinical logistics across Asia-Pacific.

This article from our latest magazine edition highlights real-world insights on biologics, cell and gene therapies, and patient-centric trial supply models.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค ๐ญ๐จ๐๐š๐ฒ: https://www.pharmafocusasia.com/magazine

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐Ÿ๐ž๐š๐ญ๐ฎ๐ซ๐ž ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž: https://www.pharmafocusasia.com/advertorials/almac-clinical-services-driving-innovation

Asia Pacific is emerging as a global biologics powerhouseโ€”but fragmented prefillable syringe development continues to sl...
07/01/2026

Asia Pacific is emerging as a global biologics powerhouseโ€”but fragmented prefillable syringe development continues to slow progress from lab to patient.

In ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐Œ๐š๐ ๐š๐ณ๐ข๐ง๐ž โ€“ ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ, ๐๐ž๐ญ๐ญ๐ข๐ง๐ž ๐๐จ๐ฅ๐ญ๐ซ๐ž๐ฌ, ๐ƒ๐ข๐ซ๐ž๐œ๐ญ๐จ๐ซ ๐จ๐Ÿ ๐’๐œ๐ข๐ž๐ง๐ญ๐ข๐Ÿ๐ข๐œ ๐€๐Ÿ๐Ÿ๐š๐ข๐ซ๐ฌ ๐š๐ญ ๐–๐ž๐ฌ๐ญ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ, highlights how integrated prefillable syringe systems can streamline development, regulatory submissions, and supply reliability for biologics and vaccines.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค: https://www.pharmafocusasia.com/magazine

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž:: https://www.pharmafocusasia.com/advertorials/from-molecule-to-market-solving-the-fragmented

Address

111,112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus Asia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pharma Focus Asia:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category